Sharon Mates $ITCI SEC Form 4 Insider Trading

Sharon Mates has filed a total of 62 insider trades in $ITCI since 2021. Their most recent trade was a sale of 27,667 shares, made on Dec 04, 2024. Their largest trade was a sale of 67,597 shares, made on Jan 18, 2024. We estimate that they now own 1.1 million shares of $ITCI, worth an estimated $94.6 million.

Insider Trading at $ITCI

There have been a total of 247 insider trades reported at $ITCI since 2021, with 0 shares purchased and 3.0 million shares sold. The most active insider traders in $ITCI stock have been Sharon Mates, Mark Neumann, and Michael Halstead. The most recent trade was a sale of 27,667 shares reported by Sharon Mates (Chairman and CEO), made on Dec 04, 2024.

$ITCI Executives and Stock Owners with Insider Trades

• Sharon Mates, Chairman, President & CEO

• Mark Neumann, EVP, Chief Commercial Officer

• Michael Halstead, EVP and General Counsel

• Lawrence J. Hineline, SVP of Finance CFO

• Sharon Mates, Chairman and CEO

• Suresh K. Durgam, EVP, Chief Medical Officer

• Lawrence J. Hineline, SVP of Finance, CFO

• Suresh K. Durgam, Chief Medical Officer

• Michael Halstead, President

• Suresh K. Durgam, SVP, Chief Medical Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.